The carrier rate of RNF213 p.R4810K in Chinese MMD and general population is about 20 ~ 30% and 0.3% respectively, accounting for less part of MMD risk [1, 3, 5, 17–19]. Here, RNF213 is linked to multiminicore myopathy.